BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36414812)

  • 1. Utility of renal biopsy in differentiating idiopathic multicentric Castleman disease from IgG4-related disease.
    Kawanishi M; Kamei F; Sonoda H; Oba M; Fukunaga S; Egawa M; Koyama T; Sato Y; Tanabe K; Ito T
    CEN Case Rep; 2023 May; 12(2):242-248. PubMed ID: 36414812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of IgG4-positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4-related disease.
    Nishikori A; Nishimura MF; Nishimura Y; Notohara K; Satou A; Moriyama M; Nakamura S; Sato Y
    Pathol Int; 2022 Jan; 72(1):43-52. PubMed ID: 34762752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic challenges of the idiopathic plasmacytic lymphadenopathy (IPL) subtype of idiopathic multicentric Castleman disease (iMCD): Factors to differentiate from IgG4-related disease.
    Nishikori A; Nishimura MF; Fajgenbaum DC; Nishimura Y; Maehama K; Haratake T; Tabata T; Kawano M; Nakamura N; Momose S; Sumiyoshi R; Koga T; Yamamoto H; van Rhee F; Kawakami A; Sato Y
    J Clin Pathol; 2024 Feb; ():. PubMed ID: 38378248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary Manifestations of Plasma Cell Type Idiopathic Multicentric Castleman Disease: A Clinicopathological Study in Comparison with IgG4-Related Disease.
    Nishimura MF; Igawa T; Gion Y; Tomita S; Inoue D; Izumozaki A; Ubara Y; Nishimura Y; Yoshino T; Sato Y
    J Pers Med; 2020 Dec; 10(4):. PubMed ID: 33321725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin G4-related disease and idiopathic multicentric Castleman's disease: confusable immune-mediated disorders.
    Sasaki T; Akiyama M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2022 Feb; 61(2):490-501. PubMed ID: 34363463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological comparison among nodal cases of idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Futatsuya C; Mizutani KI; Kumagai M; Shioya A; Guo X; Aikawa A; Nakada S; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Kojima M; Nakamura S; Yamada S
    Hum Pathol; 2018 Jul; 77():130-138. PubMed ID: 29684500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic Multicentric Castleman Disease with Strikingly Elevated IgG4 Concentration in the Serum and Abundant IgG4-Positive Cells in the Tissue: A Case Report.
    Cheng CC; Chen YC; Hsu YH; Su KY
    Diagnostics (Basel); 2022 Sep; 12(9):. PubMed ID: 36140662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyper-IL-6 syndrome mimicking IgG4-related disease].
    Terao T; Yamamoto K; Ikeuchi K; Wakabayashi H; Igawa T; Inoue D; Oda W; Oyama T; Kamoi C; Sumii Y; Shiraishi Y; Yamamoto Y; Niiya D; Shiote Y; Sato Y; Yoshino T; Imajo K
    Rinsho Ketsueki; 2019; 60(5):392-397. PubMed ID: 31168001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiopathic multicentric castleman's disease mimicking immunoglobulin G4-related disease responding well to Bortezomib: a case report.
    Peng Q; Wu F; Shi Y; Wang J; Zhai Z; Wang Z
    BMC Nephrol; 2023 Oct; 24(1):290. PubMed ID: 37784011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease.
    Fajgenbaum DC
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):318-325. PubMed ID: 30504327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease.
    Nishikori A; Nishimura MF; Nishimura Y; Otsuka F; Maehama K; Ohsawa K; Momose S; Nakamura N; Sato Y
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis.
    González García A; Fernández-Martín J; Robles Marhuenda Á
    Rheumatology (Oxford); 2023 Apr; 62(4):1426-1435. PubMed ID: 35997567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of follicular helper T cells in idiopathic multicentric Castleman disease with and without TAFRO syndrome.
    Kurose N; Guo X; Shioya A; Mizutani KI; Kumagai M; Fujimoto S; Kawabata H; Masaki Y; Takai K; Aoki S; Nakamura S; Yamada S
    Pathol Res Pract; 2019 Oct; 215(10):152563. PubMed ID: 31358479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clinical and pathological features of lung lesions of systemic IgG4-related disease and idiopathic multicentric Castleman's disease.
    Terasaki Y; Ikushima S; Matsui S; Hebisawa A; Ichimura Y; Izumi S; Ujita M; Arita M; Tomii K; Komase Y; Owan I; Kawamura T; Matsuzawa Y; Murakami M; Ishimoto H; Kimura H; Bando M; Nishimoto N; Kawabata Y; Fukuda Y; Ogura T;
    Histopathology; 2017 Jun; 70(7):1114-1124. PubMed ID: 28207938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance between transbronchial lung cryobiopsy and surgical lung biopsy in patients with idiopathic multicentric Castleman disease: A report of four cases.
    Otoshi R; Kitamura H; Baba T; Muraoka T; Sekine A; Takemura T; Okudela K; Sawazumi T; Ogura T
    Respir Investig; 2024 Jan; 62(1):1-8. PubMed ID: 37925882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic multicentric Castleman disease treated with siltuximab for 15 years: a case report.
    Lang E; Sande B; Brodkin S; van Rhee F
    Ther Adv Hematol; 2022; 13():20406207221082552. PubMed ID: 35251585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease.
    Pierson SK; Stonestrom AJ; Shilling D; Ruth J; Nabel CS; Singh A; Ren Y; Stone K; Li H; van Rhee F; Fajgenbaum DC
    Am J Hematol; 2018 Jul; 93(7):902-912. PubMed ID: 29675946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentric Castleman disease mimicking IgG4-related disease: A case report.
    Izumi Y; Takeshita H; Moriwaki Y; Hisatomi K; Matsuda M; Yamashita N; Kawahara C; Shigemitsu Y; Iwanaga N; Kawakami A; Kurohama H; Niino D; Ito M; Migita K
    Mod Rheumatol; 2017 Jan; 27(1):174-177. PubMed ID: 25528859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From Castleman disease histopathological features to idiopathic multicentric Castleman disease: a multiparametric approach to exclude potential iMCD histopathological mimickers.
    Rodriguez Merino L; Pomares AA; Arce JR; Montes-Moreno S
    J Clin Pathol; 2024 Apr; 77(5):318-323. PubMed ID: 36690434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic multicentric Castleman disease (iMCD)-idiopathic plasmacytic lymphadenopathy: A distinct subtype of iMCD-not otherwise specified with different clinical features and better survival.
    Gao YH; Liu YT; Zhang MY; Li SY; Fajgenbaum DC; Zhang L; Li J
    Br J Haematol; 2024 May; 204(5):1830-1837. PubMed ID: 38356434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.